Late-onset dementia: A mosaic of prototypical pathologies modifiable by diet and lifestyle

npj Aging and Mechanisms of Disease

Volumn 1, Issue 1, 2015, Pages

  Mattson, Mark P ^a,b  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84994649556     PISSN: None     EISSN: 20563973     Source Type: Journal    
DOI: 10.1038/npjamd.2015.3     Document Type: Review

References (165)

1. Dowling NM, Tomaszewski Farias S, Reed BR, Sonnen JA, Strauss ME, Schneider JA et al. Neuropathological associates of multiple cognitive functions in two community-based cohorts of older adults. J Int Neuropsychol Soc 2011; 17: 602–614.
2. Cholerton B, Larson EB, Baker LD, Craft S, Crane PK, Millard SP et al. Neuropathologic correlates of cognition in a population-based sample. J Alzheimers Dis 2013; 36: 699–709.
3. Wilson RS, Yu L, Trojanowski JQ, Chen EY, Boyle PA, Bennett DA et al. TDP-43 pathology, cognitive decline, and dementia in old age. JAMA Neurol 2013; 70: 1418–1424.
4. Bertram L, Lill CM, Tanzi RE. The genetics of Alzheimer disease: back to the future. Neuron 2010; 68: 270–281.
5. Shinohara M, Fujioka S, Murray ME, Wojtas A, Baker M, Rovelet-Lecrux A et al. Regional distribution of synaptic markers and APP correlate with distinct clin-icopathological features in sporadic and familial Alzheimer's disease. Brain 2014; 137: 1533–1549.
6. Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC et al. Alzheimers Dement 2012; 8: 1–13.
7. Geddes JW, Tekirian TL, Soultanian NS, Ashford JW, Davis DG, Markesbery WR. Comparison of neuropathologic criteria for the diagnosis of Alzheimer's disease. Neurobiol Aging 1997; 18: S99–S105.
8. Bezprozvanny I, Mattson MP. Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease. Trends Neurosci 2008; 31: 454–463.
9. Ghetti B, Oblak AL, Boeve BF, Johnson KA, Dickerson BC, Goedert M. Invited review: Frontotemporal dementia caused by microtubule-associated proteintau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging. Neuropathol Appl Neurobiol 2015; 41: 24–46.
10. Benajiba L, Le Ber I, Camuzat A, Lacoste M, Thomas-Anterion C, Couratier P et al. TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration. Ann Neurol 2009; 65: 470–473.
11. Renton AE, Majounie E, Waite A, Simón-Sánchez J, Rollinson S, Gibbs JR et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011; 72: 257–268.
12. Mori K, Weng SM, Arzberger T, May S, Rentzsch K, Kremmer E et al. The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science 2013; 339: 1335–1338.
13. Nelson PT, Smith CD, Abner EL, Wilfred BJ, Wang WX, Neltner JH et al. Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease. Acta Neuropathol 2013; 126: 161–177.
14. Dickson DW, Baker M, Rademakers R. Common variant in GRN is a genetic risk factor for hippocampal sclerosis in the elderly. Neurodegener Dis 2010; 7: 170–174.
15. Nelson PT, Estus S, Abner EL, Parikh I, Malik M, Neltner JH et al. ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology. Acta Neuropathol 2014; 127: 825–843.
16. Nelson PT, Wang WX, Partch AB, Monsell SE, Valladares O, Ellingson SR et al. Reassessment of risk genotypes (GRN, TMEM106B, and ABCC9 variants) associated withhippocampal sclerosis of aging pathology. J Neuropathol Exp Neurol 2015; 74: 75–84.
17. Hanson JC, Lippa CF. Lewy body dementia. Int Rev Neurobiol 2009; 84: 215–228.
18. Ferencz B, Gerritsen L. Genetics and underlying pathology of dementia. Neuropsychol Rev 2015; 25: 113–124.
19. Jellinger KA. Neurobiology of cognitive impairment in Parkinson's disease. Expert Rev Neurother 2012; 12: 1451–1466.
20. Houlden H, Singleton AB. The genetics and neuropathology of Parkinson's disease. Acta Neuropathol 2012; 124: 325–338.
21. Venderova K, Park DS. Programmed cell death in Parkinson's disease. Cold Spring Harb Perspect Med 2012; 2: pii: a009365.
22. Kovacs GG, Milenkovic I, Wöhrer A, Höftberger R, Gelpi E, Haberler C et al. Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series. Acta Neuropathol 2013; 126: 365–384.
23. Josephs KA, Whitwell JL, Weigand SD, Murray ME, Tosakulwong N et al. TDP-43 is a key player in the clinical features associated with Alzheimer's disease. Acta Neuropathol 2014; 127: 811–824.
24. Neltner JH, Abner EL, Baker S, Schmitt FA, Kryscio RJ, Jicha GA et al. Arteriolo-sclerosis that affects multiple brain regions is linked to hippocampal sclerosis of ageing. Brain 2014; 137: 255–267.
25. Serrano-Pozo A, Qian J, Monsell SE, Blacker D, Gómez-Isla T, Betensky RA et al. Mild to moderate Alzheimer dementia with insufficient neuropathological changes. Ann Neurol 2014; 75: 597–601.
26. Aoki N, Murray ME, Ogaki K, Fujioka S, Rutherford NJ, Rademakers R et al. Hippocampal sclerosis in Lewy body disease is a TDP-43 proteinopathy similar to FTLD-TDP type A. Acta Neuropathol 2015; 129: 53–64.
27. Rosenberg CK, Pericak-Vance MA, Saunders AM, Gilbert JR, Gaskell PC, Hulette CM. Lewy body and Alzheimer pathology in a family with the amyloid-beta precursor protein APP717 gene mutation. Acta Neuropathol 2000; 100: 145–152.
28. Snider BJ, Norton J, Coats MA, Chakraverty S, Hou CE, Jervis R et al. Novel presenilin 1 mutation (S170F) causing Alzheimer disease with Lewy bodies in the third decade of life. Arch Neurol 2005; 62: 1821–1830.
29. Mattson MP. Pathways towards and away from Alzheimer’s disease. Nature 2004; 430: 631–639.
30. Mattson MP. Energy intake and exercise as determinants of brain health and vulnerability to injury and disease. Cell Metab 2012; 16: 706–722.
31. Driscoll I, Troncoso J. Asymptomatic Alzheimer's disease: a prodrome or a state of resilience? Curr Alzheimer Res 2011; 8: 330–335.
32. Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ et al. Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol 2012; 71: 362–381.
33. Robinson JL, Molina-Porcel L, Corrada MM, Raible K, Lee EB, Lee VM et al. Per-forant path synaptic loss correlates with cognitive impairment and Alzheimer's disease in the oldest-old. Brain 2014; 137: 2578–2587.
34. Scheff SW, Neltner JH, Nelson PT. Is synaptic loss a unique hallmark of Alzheimer's disease? Biochem Pharmacol 2014; 88: 517–528.
35. Spires-Jones TL, Hyman BT. The intersection of amyloid beta and tau at synapses in Alzheimer's disease. Neuron 2014; 82: 756–771.
36. Collins RC, Dobkin BH, Choi DW. Selective vulnerability of the brain: new insights into the pathophysiology of stroke. Ann Intern Med 1989; 110: 992–1000.
37. Mattson MP, Magnus T. Ageing and neuronal vulnerability. Nat Rev Neurosci 2006; 7: 278–294.
38. Gleichmann M, Chow VW, Mattson MP. Homeostatic disinhibition in the aging brain and Alzheimer’s disease. J Alzheimers Dis 2011; 24: 15–24.
39. Gillingwater TH, Wishart TM. Mechanisms underlying synaptic vulnerability and degeneration in neurodegenerative disease. Neuropathol Appl Neurobiol 2013; 39: 320–334.
40. Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel RE. beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 1992; 12: 376–389.
41. 2+ homeostasis and cell death. J Neurosci 1995; 15: 6239–6249.
42. Mark RJ, Pang Z, Geddes JW, Uchida K, Mattson MP. Amyloid beta-peptide impairs glucose transport in hippocampal and cortical neurons; involvement of membrane lipid peroxidation. J Neurosci 1997; 17: 1046–1054.
43. Keller JN, Pang Z, Geddes JW, Begley JG, Germeyer A, Waeg G et al. Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid beta-peptide: role of the lipid peroxidation product 4-hydroxynonenal. J Neurochem 1997; 69: 273–284.
44. Koistinaho M, Kettunen MI, Goldsteins G, Keinänen R, Salminen A, Ort M et al. Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammation. Proc Natl Acad Sci USA 2002; 99: 1610–1615.
45. Huang X, Moir RD, Tanzi RE, Bush AI, Rogers JT. Redox-active metals, oxidative stress, and Alzheimer's disease pathology. Ann N Y Acad Sci 2004; 1012: 153–163.
46. Fang F, Lue LF, Yan S, Xu H, Luddy JS, Chen D et al. RAGE-dependent signaling in microglia contributes to neuroinflammation, Abeta accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease. FASEB J 2010; 24: 1043–1055.
47. Harris H, Rubinsztein DC. Control of autophagy as a therapy for neurodegenerative disease. Nat Rev Neurol 2011; 8: 108–117.
48. Nixon RA. The role of autophagy in neurodegenerative disease. Nat Med 2013; 19: 983–997.
49. Quiroz-Baez R, Flores-Domínguez D, Arias C. Synaptic aging is associated with mitochondrial dysfunction, reduced antioxidant contents and increased vulnerability to amyloid-β toxicity. Curr Alzheimer Res 2013; 10: 324–331.
50. Phillips HS, Hains JM, Armanini M, Laramee GR, Johnson SA, Winslow JW. BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer’s disease. Neuron 1991; 7: 695–702.
51. Talbot K, Wang HY, Kazi H, Han LY, Bakshi KP, Stucky A et al. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest 2012; 122: 1316–1338.
52. Arancibia S, Silhol M, Moulière F, Meffre J, Höllinger I, Maurice T et al. Protective effect of BDNF against beta-amyloid induced neurotoxicity in vitro and in vivo in rats. Neurobiol Dis 2008; 31: 316–326.
53. Kitiyanant N, Kitiyanant Y, Svendsen CN, Thangnipon W. BDNF-, IGF-1-and GDNF-secreting human neural progenitor cells rescue amyloid β-induced toxicity in cultured rat septal neurons. Neurochem Res 2012; 37: 143–152.
54. Cheng B, Mattson MP. Glucose deprivation elicits neurofibrillary tangle-like antigenic changes in hippocampal neurons: prevention by NGF and bFGF. Exp Neurol 1992; 117: 114–123.
55. Horiguchi T, Uryu K, Giasson BI, Ischiropoulos H, LightFoot R, Bellmann C et al. Nitration of tau protein is linked to neurodegeneration in tauopathies. Am J Pathol 2003; 163: 1021–1031.
56. Mattson MP. Antigenic changes similar to those seen in neurofibrillary tangles are elicited by glutamate and Ca2+ influx in cultured hippocampal neurons. Neuron 1990; 4: 105–117.
57. Furukawa K, Wang Y, Yao PJ, Fu W, Mattson MP, Itoyama Y et al. Alteration in calcium channel properties is responsible for the neurotoxic action of a familial frontotemporal dementia tau mutation. J Neurochem 2003; 87: 427–436.
58. Congdon EE, Wu JW, Myeku N, Figueroa YH, Herman M, Marinec PS et al. Methylthionimium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo. Autophagy 2012; 8: 609–622.
59. Tong J, Huang C, Bi F, Wu Q, Huang B, Liu X et al. Expression of ALS-linked TDP-43 mutant in astrocytes causes non-cell-autonomous motor neuron death in rats. EMBO J 2013; 32: 1917–1926.
60. Stribl C, Samara A, Trümbach D, Peis R, Neumann M, Fuchs H et al. Mitochondrial dysfunction and decrease in body weight of a transgenic knock-in mouse model for TDP-43. J Biol Chem 2014; 289: 10769–10784.
61. Wang W, Li L, Lin WL, Dickson DW, Petrucelli L, Zhang T et al. The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons. Hum Mol Genet 2013; 22: 4706–4719.
62. Wang IF, Guo BS, Liu YC, Wu CC, Yang CH, Tsai KJ et al. Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteino-pathies of the TAR DNA-binding protein 43. Proc Natl Acad Sci USA 2012; 109: 15024–15029.
63. Yao Z, Wood NW. Cell death pathways in Parkinson's disease: role of mitochondria. Antioxid Redox Signal 2009; 11: 2135–2149.
64. Dimant H, Ebrahimi-Fakhari D, McLean PJ. Molecular chaperones and co-chaperones in Parkinson disease. Neuroscientist 2012; 18: 589–601.
65. Lim Y, Kehm VM, Lee EB, Soper JH, Li C, Trojanowski JQ et al. α-Syn suppression reverses synaptic and memory defects in a mouse model of dementia with Lewy bodies. J Neurosci 2011; 31: 10076–10087.
66. Epel ES, Lithgow GJ. Stress biology and aging mechanisms: toward understanding the deep connection between adaptation to stress and longevity. J Gerontol A Biol Sci Med Sci 2014; 69: S10–S16.
67. Haigis MC, Yankner BA. The aging stress response. Mol Cell 2010; 40: 333–344.
68. McEwen BS, Morrison JH. The brain on stress: vulnerability and plasticity of the prefrontal cortex over the life course. Neuron 2013; 79: 16–29.
69. Miller DB, O'Callaghan JP. Aging, stress and the hippocampus. Ageing Res Rev 2005; 4: 123–140.
70. Texel SJ, Mattson MP. Impaired adaptive cellular responses to oxidative stress and the pathogenesis of Alzheimer's disease. Antioxid Redox Signal 2011; 14: 1519–1534.
71. Rothman SM, Mattson MP. Activity-dependent, stress-responsive BDNF signaling and the quest for optimal brain health and resilience throughout the lifespan. Neuroscience 2013; 239: 228–240.
72. Li G, Peskind ER, Millard SP, Chi P, Sokal I, Yu CE et al. Cerebrospinal fluid concentration of brain-derived neurotrophic factor and cognitive function in non-demented subjects. PLoS One 2009; 4: e5424.
73. Calabrese F, Guidotti G, Racagni G, Riva MA. Reduced neuroplasticity in aged rats: a role for the neurotrophin brain-derived neurotrophic factor Neurobiol Aging 2013; 34: 2768–2776.
74. Sen A, Nelson TJ, Alkon DL. ApoE4 and Aβ oligomers reduce BDNF expression via HDAC nuclear translocation. J Neurosci 2015; 35: 7538–7551.
75. Nagahara AH, Merrill DA, Coppola G, Tsukada S, Schroeder BE, Shaked GM et al. Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease. Nat Med 2009; 15: 331–337.
76. Cheng A, Wan R, Yang JL, Kamimura N, Son TG, Ouyang X et al. Involvement of PGC-1α in the formation and maintenance of neuronal dendritic spines. Nat Commun 2012; 3: 1250.
77. Arumugam TV, Phillips TM, Cheng A, Morrell CH, Mattson MP, Wan R. Age and energy intake interact to modify cell stress pathways and stroke outcome. Ann Neurol 2010; 67: 41–52.
78. Keller JN, Kindy MS, Holtsberg FW, St Clair DK, Yen HC, Germeyer A et al. Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J Neurosci 1998; 18: 687–697.
79. Esposito L, Raber J, Kekonius L, Yan F, Yu GQ, Bien-Ly N et al. Reduction in mitochondrial superoxide dismutase modulates Alzheimer's disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice. J Neurosci 2006; 26: 5167–5179.
80. Melov S, Adlard PA, Morten K, Johnson F, Golden TR, Hinerfeld D et al. Mitochondrial oxidative stress causes hyperphosphorylation of tau. PLoS One 2007; 2: e536.
81. Mattson MP, Meffert MK. Roles for NF-kappaB in nerve cell survival, plasticity, and disease. Cell Death Differ 2006; 13: 852–860.
82. Mazzuferi M, Kumar G, van Eyll J, Danis B, Foerch P, Kaminski RM. Nrf2 defense pathway: experimental evidence for its protective role in epilepsy. Ann Neurol 2013; 74: 560–568.
83. Hyun DH, Emerson SS, Jo DG, Mattson MP, de Cabo R. Calorie restriction upregulates the plasma membrane redox system in brain cells and suppresses oxidative stress during aging. Proc Natl Acad Sci USA 2006; 103: 19908–19912.
84. Hyun DH, Mughal MR, Yang H, Lee JH, Ko EJ, Hunt ND et al. The plasma membrane redox system is impaired by amyloid β-peptide and in the hippocampus and cerebral cortex of 3xTgAD mice. Exp Neurol 2010; 225: 423–429.
85. Navarro A, Boveris A. The mitochondrial energy transduction system and the aging process. Am J Physiol Cell Physiol 2007; 292: C670–C686.
86. Mattson MP, Gleichmann M, Cheng A. Mitochondria in neuroplasticity and neurological disorders. Neuron 2008; 60: 748–766.
87. Martin LJ. Biology of mitochondria in neurodegenerative diseases. Prog Mol Biol Transl Sci 2012; 107: 355–415.
88. Yang JL, Weissman L, Bohr VA, Mattson MP. Mitochondrial DNA damage and repair in neurodegenerative disorders. DNA Repair (Amst) 2008; 7: 1110–1120.
89. Gibson GE, Starkov A, Blass JP, Ratan RR, Beal MF. Cause and consequence: mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases. Biochim Biophys Acta 2010; 1802: 122–134.
90. Green KN, Steffan JS, Martinez-Coria H, Sun X, Schreiber SS, Thompson LM et al. Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau. J Neurosci 2008; 28: 11500–11510.
91. Kashiwaya Y, Bergman C, Lee JH, Wan R, King MT, Mughal MR et al. A ketone ester diet exhibits anxiolytic and cognition-sparing properties, and lessens amyloid and tau pathologies in a mouse model of Alzheimer's disease. Neurobiol Aging 2013; 34: 1530–1539.
92. Liu D, Pitta M, Lee JH, Ray B, Lahiri DK, Furukawa K et al. The KATP channel activator diazoxide ameliorates amyloid-β and tau pathologies and improves memory in the 3xTgAD mouse model of Alzheimer's disease. J Alzheimers Dis 2010; 22: 443–457.
93. Foster TC. Calcium homeostasis and modulation of synaptic plasticity in the aged brain. Aging Cell 2007; 6: 319–325.
94. Toescu EC, Verkhratsky A. Parameters of calcium homeostasis in normal neuronal ageing. J Anat 2000; 197: 563–569.
95. Lipton SA. The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonism. Curr Alzheimer Res 2005; 2: 155–165.
96. Calì T, Ottolini D, Brini M. Calcium signaling in Parkinson's disease. Cell Tissue Res 2014; 357: 439–454.
97. Veinbergs I, Everson A, Sagara Y, Masliah E. Neurotoxic effects of apolipoprotein E4 are mediated via dysregulation of calcium homeostasis. J Neurosci Res 2002; 67: 379–387.
98. Zheng C, Geetha T, Babu JR. Failure of ubiquitin proteasome system: risk for neurodegenerative diseases. Neurodegener Dis 2014; 14: 161–175.
99. Alvarez-Castelao B, Goethals M, Vandekerckhove J, Castaño JG. Mechanism of cleavage of alpha-synuclein by the 20S proteasome and modulation of its degradation by the RedOx state of the N-terminal methionines. Biochim Biophys Acta 2014; 1843: 352–365.
100. Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J et al. alpha-Synuclein locus triplication causes Parkinson's disease. Science 2003; 302: 841.
101. Karbowski M, Neutzner A. Neurodegeneration as a consequence of failed mitochondrial maintenance. Acta Neuropathol 2012; 123: 157–171.
102. Medina DX, Caccamo A, Oddo S. Methylene blue reduces Aβ levels and rescues early cognitive deficit by increasing proteasome activity. Brain Pathol 2011; 21: 140–149.
103. Lu T, Pan Y, Kao SY, Li C, Kohane I, Chan J et al. Gene regulation and DNA damage in the ageing human brain. Nature 2004; 429: 883–891.
104. Canugovi C, Yoon JS, Feldman NH, Croteau DL, Mattson MP, Bohr VA. Endonuclease VIII-like 1 (NEIL1) promotes short-term spatial memory retention and protects from ischemic stroke-induced brain dysfunction and death in mice. Proc Natl Acad Sci USA 2012; 109: 14948–14953.
105. Liu D, Croteau DL, Souza-Pinto N, Pitta M, Tian J, Wu C et al. Evidence that OGG1 glycosylase protects neurons against oxidative DNA damage and cell death under ischemic conditions. J Cereb Blood Flow Metab 2011; 31: 680–692.
106. Sykora P, Misiak M, Wang Y, Ghosh S, Leandro GS, Liu D et al. DNA polymerase β deficiency leads to neurodegeneration and exacerbates Alzheimer disease phenotypes. Nucleic Acids Res 2015; 43: 943–959.
107. Yang JL, Lin YT, Chuang PC, Bohr VA, Mattson MP. BDNF and exercise enhance neuronal DNA repair by stimulating CREB-mediated production of apurinic/ apyrimidinic endonuclease 1. Neuromol Med 2014; 16: 161–174.
108. Yang JL, Tadokoro T, Keijzers G, Mattson MP, Bohr VA. Neurons efficiently repair glutamate-induced oxidative DNA damage by a process involving CREB-mediated up-regulation of apurinic endonuclease 1. J Biol Chem 2010; 285: 28191–28199.
109. Stranahan AM, Mattson MP. Recruiting adaptive cellular stress responses for successful brain ageing. Nat Rev Neurosci 2012; 13: 209–216.
110. van Praag H, Fleshner M, Schwartz MW, Mattson MP. Exercise, energy intake, glucose homeostasis, and the brain. J Neurosci 2014; 34: 15139–15149.
111. Sale A, Berardi N, Maffei L. Enrich the environment to empower the brain. Trends Neurosci 2009; 32: 233–239.
112. Brené S, Bjørnebekk A, Aberg E, Mathé AA, Olson L, Werme M. Running is rewarding and antidepressive. Physiol Behav 2007; 92: 136–140.
113. Stein DJ, Collins M, Daniels W, Noakes TD, Zigmond M. Mind and muscle: the cognitive-affective neuroscience of exercise. CNS Spectr 2007; 12: 19–22.
114. Erickson KI, Voss MW, Prakash RS, Basak C, Szabo A, Chaddock L et al. Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci USA 2011; 108: 3017–3022.
115. Voss MW, Heo S, Prakash RS, Erickson KI, Alves H, Chaddock L et al. The influence of aerobic fitness on cerebral white matter integrity and cognitive function in older adults: results of a one-year exercise intervention. Hum Brain Mapp 2013; 34: 2972–2985.
116. Dimatelis JJ, Hendricks S, Hsieh J, Vlok NM, Bugarith K, Daniels WM et al. Exercise partly reverses the effect of maternal separation on hippocampal proteins in 6-hydroxydopamine-lesioned rat brain. Exp Physiol 2013; 98: 233–244.
117. Erickson KI, Weinstein AM, Lopez OL. Physical activity, brain plasticity, and Alzheimer's disease. Arch Med Res 2012; 43: 615–621.
118. García-Mesa Y, López-Ramos JC, Giménez-Llort L, Revilla S, Guerra R, Gruart A et al. Physical exercise protects against Alzheimer's disease in 3xTg-AD mice. J Alzheimers Dis 2011; 24: 421–454.
119. Halagappa VK, Guo Z, Pearson M, Matsuoka Y, Cutler RG, Laferla FM et al. Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer's disease. Neurobiol Dis 2007; 26: 212–220.
120. Patel NV, Gordon MN, Connor KE, Good RA, Engelman RW, Mason J et al. Caloric restriction attenuates Abeta-deposition in Alzheimer transgenic models. Neurobiol Aging 2005; 26: 995–1000.
121. Wang J, Ho L, Qin W, Rocher AB, Seror I, Humala N et al. Caloric restriction attenuates beta-amyloid neuropathology in a mouse model of Alzheimer's disease. FASEB J 2005; 19: 659–661.
122. Lahiani-Cohen I, Lourbopoulos A, Haber E, Rozenstein-Tsalkovich L, Abramsky O, Grigoriadis N et al. Moderate environmental enrichment mitigates tauopathy in a neurofibrillary tangle mouse model. J Neuropathol Exp Neurol 2011; 70: 610–621.
123. Maesako M, Uemura K, Kubota M, Kuzuya A, Sasaki K, Asada M et al. Environmental enrichment ameliorated high-fat diet-induced Aβ deposition and memory deficit in APP transgenic mice. Neurobiol Aging 2012; 33, 1011 e11–e23.
124. Luchsinger JA, Cheng D, Tang MX, Schupf N, Mayeux R. Central obesity in the elderly is related to late-onset Alzheimer disease. Alzheimer Dis Assoc Disord 2012; 26: 101–105.
125. Xu WL, Atti AR, Gatz M, Pedersen NL, Johansson B, Fratiglioni L. Midlife overweight and obesity increase late-life dementia risk: a population-based twin study. Neurology 2011; 76: 1568–1574.
126. Meng X, D'Arcy C. Education and dementia in the context of the cognitive reserve hypothesis: a systematic review with meta-analyses and qualitative analyses. PLoS One 2012; 7: e38268.
127. Longo VD, Mattson MP. Fasting: molecular mechanisms and clinical applications. Cell Metab 2014; 19: 181–192.
128. Spindler SR. Caloric restriction: from soup to nuts. Ageing Res Rev 2010; 9: 324–353.
129. Bruce-Keller AJ, Umberger G, McFall R, Mattson MP. Food restriction reduces brain damage and improves behavioral outcome following excitotoxic and metabolic insults. Ann Neurol 1999; 45: 8–15.
130. Duan W, Guo Z, Jiang H, Ware M, Li XJ, Mattson MP. Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice. Proc Natl Acad Sci USA 2003; 100: 2911–2916.
131. Griffioen KJ, Rothman SM, Ladenheim B, Wan R, Vranis N, Hutchison E et al. Dietary energy intake modifies brainstem autonomic dysfunction caused by mutant α-synuclein. Neurobiol Aging 2013; 34: 928–935.
132. Dubey A, Forster MJ, Lal H, Sohal RS. Effect of age and caloric intake on protein oxidation in different brain regions and on behavioral functions of the mouse. Arch Biochem Biophys 1996; 333: 189–197.
133. Johnson JB, Summer W, Cutler RG, Martin B, Hyun DH, Dixit VD et al. Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthma. Free Radic Biol Med 2007; 42: 665–674.
134. Singh R, Lakhanpal D, Kumar S, Sharma S, Kataria H, Kaur M et al. Late-onset intermittent fasting dietary restriction as a potential intervention to retard age-associated brain function impairments in male rats. Age (Dordr) 2012; 34: 917–933.
135. Lin AL, Coman D, Jiang L, Rothman DL, Hyder F. Caloric restriction impedes age-related decline of mitochondrial function and neuronal activity. J Cereb Blood Flow Metab 2014; 34: 1440–1443.
136. Maalouf M, Rho JM, Mattson MP. The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain Res Rev 2009; 59: 293–315.
137. Youssef FF, Ramchandani J, Manswell S, McRae A. Adult-onset calorie restriction attenuates kainic acid excitotoxicity in the rat hippocampal slice. Neurosci Lett 2008; 431: 118–122.
138. Ugochukwu NH, Mukes JD, Figgers CL. Ameliorative effects of dietary caloric restriction on oxidative stress and inflammation in the brain of streptozotocin-induced diabetic rats. Clin Chim Acta 2006; 370: 165–173.
139. Goodrick CL. Effects of long-term voluntary wheel exercise on male and female Wistar rats. I. Longevity, body weight, and metabolic rate. Gerontology 1980; 26: 22–33.
140. Holloszy JO, Schechtman KB. Interaction between exercise and food restriction: effects on longevity of male rats. J Appl Physiol (1985) 1991; 70: 1529–1535.
141. Parachikova A, Nichol KE, Cotman CW. Short-term exercise in aged Tg2576 mice alters neuroinflammation and improves cognition. Neurobiol Dis 2008; 30: 121–129.
142. Stranahan AM, Lee K, Martin B, Maudsley S, Golden E, Cutler RG et al. Voluntary exercise and caloric restriction enhance hippocampal dendritic spine density and BDNF levels in diabetic mice. Hippocampus 2009; 19: 951–961.
143. Stranahan AM, Lee K, Becker KG, Zhang Y, Maudsley S, Martin B et al. Hippocampal gene expression patterns underlying the enhancement of memory by running in aged mice. Neurobiol Aging 2010; 31: 1937–1949.
144. Herring A, Blome M, Ambrée O, Sachser N, Paulus W, Keyvani K. Reduction of cerebral oxidative stress following environmental enrichmentin mice with Alzheimer-like pathology. Brain Pathol 2010; 20: 166–175.
145. Herring A, Lewejohann L, Panzer AL, Donath A, Kröll O, Sachser N et al. Preventive and therapeutic types of environmental enrichment counteract beta amyloid pathology by different molecular mechanisms. Neurobiol Dis 2011; 42: 530–538.
146. Kesslak JP, So V, Choi J, Cotman CW, Gomez-Pinilla F. Learning upregulates brain-derived neurotrophic factor messenger ribonucleic acid: a mechanism to facilitate encoding and circuit maintenance? Behav Neurosci 1998; 112: 1012–1019.
147. Oliff HS, Berchtold NC, Isackson P, Cotman CW. Exercise-induced regulation of brain-derived neurotrophic factor (BDNF) transcripts in the rat hippocampus. Brain Res Mol Brain Res 1998; 61: 147–153.
148. Llorens-Martín M, Torres-Alemán I, Trejo JL. Growth factors as mediators of exercise actions on the brain. Neuromol Med 2008; 10: 99–107.
149. Hsiao YH, Hung HC, Chen SH, Gean PW. Social interaction rescues memory deficit in an animal model of Alzheimer's disease by increasing BDNF-dependent hippocampal neurogenesis. J Neurosci 2014; 34: 16207–16219.
150. Voss MW, Erickson KI, Prakash RS, Chaddock L, Kim JS, Alves H et al. Neuro-biological markers of exercise-related brain plasticity in older adults. Brain Behav Immun 2013; 28: 90–99.
151. Sonntag WE, Ramsey M, Carter CS. Growth hormone and insulin-like growth factor-1 (IGF-1) and their influence on cognitive aging. Ageing Res Rev 2005; 4: 195–212.
152. Trejo JL, Carro E, Lopez-Lopez C, Torres-Aleman I. Role of serum insulin-like growth factor I in mammalian brain aging. Growth Horm IGF Res 2004; 14 Suppl A: S39–S43.
153. Yan H, Mitschelen M, Bixler GV, Brucklacher RM, Farley JA, Han S et al. Circulating IGF1 regulates hippocampal IGF1 levels and brain gene expression during adolescence. J Endocrinol 2011; 211: 27–37.
154. Holloszy JO. Regulation of mitochondrial biogenesis and GLUT4 expression by exercise. Compr Physiol 2011; 1: 921–940.
155. Steiner JL, Murphy EA, McClellan JL, Carmichael MD, Davis JM. Exercise training increases mitochondrial biogenesis in the brain. J Appl Physiol (1985) 2011; 111: 1066–1071.
156. Passingham RE, Wise SP. The Neurobiology of the Prefrontal Cortex: Anatomy, Evolution and the Origin of Insight. Oxford University Press: Oxford, UK, 2012.
157. Silver MA, Kastner S. Topographic maps in human frontal and parietal cortex. Trends Cogn Sci 2009; 13: 488–495.
158. Mattson MP. Superior pattern processing is the essence of the evolved human brain. Front Neurosci 2014; 8: 265.
159. Creer DJ, Romberg C, Saksida LM, van Praag H, Bussey TJ. Running enhances spatial pattern separation in mice. Proc Natl Acad Sci USA 2010; 107: 2367–2372.
160. Bielak AA, Cherbuin N, Bunce D, Anstey KJ. Preserved differentiation between physical activity and cognitive performance across young, middle, and older adulthood over 8 years. J Gerontol B Psychol Sci Soc Sci 2014; 69: 523–532.
161. Nouchi R, Taki Y, Takeuchi H, Sekiguchi A, Hashizume H, Nozawa T et al. Four weeks of combination exercise training improved executive functions, episodic memory, and processing speed in healthy elderly people: evidence from a randomized controlled trial. Age (Dordr) 2014; 36: 787–799.
162. Calabrese EJ, Bachmann KA, Bailer AJ, Bolger PM, Borak J, Cai L et al. Biological stress response terminology: integrating the concepts of adaptive response and preconditioning stress within a hormetic dose-response framework. Toxicol Appl Pharmacol 2007; 222: 122–128.
163. Rattan SI. Hormesis in aging. Ageing Res Rev 2008; 7: 63–78.
164. Calabrese EJ, Mattson MP. Hormesis provides a generalized quantitative estimate of biological plasticity. J Cell Commun Signal 2011; 5: 25–38.
165. Lee J, Jo DG, Park D, Chung HY, Mattson MP. Adaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous system. Pharmacol Rev 2014; 66: 815–868.